The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of clinical anesthesia"
DOI: 10.1016/j.jclinane.2020.110020
Abstract: STUDY OBJECTIVE Activated clotting time (ACT) is a non-specific test to evaluate the adequacy of systemic heparinization whose value could be influenced by many factors. Tranexamic acid (TXA) is a widely used antifibrinolytic agent worldwide… read more here.
Keywords: analysis; tranexamic acid; clotting time; activated clotting ... See more keywords
In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients
Sign Up to like & getrecommendations! Published in 2021 at "Haemophilia"
DOI: 10.1111/hae.14452
Abstract: Heparin management in hemophilia A (HA) patients with a factor VIII (FVIII) inhibitor can be challenging due to severe activated clotting time (ACT) prolongations. It is important to better understand the impact of emicizumab, a… read more here.
Keywords: emicizumab activated; vitro effects; activated clotting; clotting time ... See more keywords
Emicizumab does not interfere with the activated clotting time
Sign Up to like & getrecommendations! Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14497
Abstract: The activated clotting time (ACT) is a useful marker of unfractionated heparin (UFH) activity during cardiopulmonary bypass (CPB) or cardiac catheterization. Emicizumab, recently approved for bleeding prevention in haemophilia A patients, acts like FVIII but… read more here.
Keywords: emicizumab interfere; interfere activated; activated clotting; clotting time ... See more keywords
Variability of Activated Clotting Time by Site of Sample Draw During Percutaneous Coronary Intervention: A Prospective Single-Center Study
Sign Up to like & getrecommendations! Published in 2021 at "Angiology"
DOI: 10.1177/0003319721992237
Abstract: The activated clotting time (ACT) assay is used to monitor and titrate anticoagulation therapy with unfractionated heparin during percutaneous coronary intervention (PCI). Observations at our institution suggested a considerable difference between ACT values drawn from… read more here.
Keywords: act; clotting time; study; percutaneous coronary ... See more keywords
Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostics"
DOI: 10.3390/diagnostics13081489
Abstract: Activated clotting time (ACT) is used in cardiac surgery for monitoring unfractionated heparin (UFH). In endovascular radiology, ACT use is less established. We aimed to test the validity of ACT in UFH monitoring in endovascular… read more here.
Keywords: radiology; activated clotting; clotting time; time act ... See more keywords